Mass spectrometry characterization of DOTA-Nimotuzumab conjugate as precursor of an innovative βâ tracer suitable in radio-guided surgery
Keywords: پادتنهای تَکتیره; NIM; Nimotuzumab; p-SCN-Bn-DOTA or DOTA; S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraaza cyclododecanetetraacetic acid; RGS; radio-guided surgery; RGS-βâ; RGS able to detect βâ radiation; mAb; monoclonal antibody; EGFr; Epidermal Growth Factor recept